Tolerance Therapeutics

Sponsored By 

Chair(s)

• 

  Gerald Nepom, MD PhD

  Director
  Benaroya Research Institute / Immune Tolerance Network
  Seattle, Washington, United States

Presentations:

• 1:00 PM – 1:25 PM  

  IL-2 and Tregs in the Therapy of Autoimmune and Inflammatory Diseases
  

  Speaker: David Klatzmann, MD, PhD – Sorbonne Université
• 1:25 PM – 1:40 PM  

  Pathophysiological Mechanisms and Molecular Indicators of IPEX Disease and Their Implications for the Development of New Therapies
  

  Presenting Author: Šimon Borna, Ph.D. – Stanford University
• 1:40 PM – 2:05 PM  

  Donor Negative Vaccine for Transplantation Tolerance
  

  Speaker: Xunrong Luo, MD, PhD – Duke University
• 2:05 PM – 2:20 PM  

  Blood TCR Signatures Classify Autoimmune Diseases and Predict Response to Low-dose IL-2
  

  Presenting Author: Encarnita Mariotti-Ferrandiz, Ph.D. – Sorbonne Université
• 2:20 PM – 2:45 PM  

  Re-programing Autoreactivity to Suppress Autoimmunity
  

  Speaker: Pere Santamaria, MD, PhD – University of Calgary